I. Schweitzer

1.4k total citations
37 papers, 1.1k citations indexed

About

I. Schweitzer is a scholar working on Psychiatry and Mental health, Pharmacology and Behavioral Neuroscience. According to data from OpenAlex, I. Schweitzer has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Psychiatry and Mental health, 10 papers in Pharmacology and 7 papers in Behavioral Neuroscience. Recurrent topics in I. Schweitzer's work include Treatment of Major Depression (10 papers), Stress Responses and Cortisol (7 papers) and Tryptophan and brain disorders (6 papers). I. Schweitzer is often cited by papers focused on Treatment of Major Depression (10 papers), Stress Responses and Cortisol (7 papers) and Tryptophan and brain disorders (6 papers). I. Schweitzer collaborates with scholars based in Australia, United Kingdom and United States. I. Schweitzer's co-authors include John T. O’Brien, David Ames, Patricia Desmond, Brian Tress, Edmond Chiu, K P Maguire, Virginia Tuckwell, J. W. G. Tiller, Jerome Sarris and Bronwyn Davies and has published in prestigious journals such as New England Journal of Medicine, Biological Psychiatry and The British Journal of Psychiatry.

In The Last Decade

I. Schweitzer

35 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. Schweitzer Australia 19 344 162 147 143 138 37 1.1k
Chengge Gao China 22 205 0.6× 255 1.6× 219 1.5× 89 0.6× 165 1.2× 48 1.3k
Yaffa Vered Israel 19 221 0.6× 80 0.5× 70 0.5× 101 0.7× 68 0.5× 32 1.0k
Lars‐Håkan Thorell Sweden 22 125 0.4× 148 0.9× 85 0.6× 157 1.1× 146 1.1× 55 1.2k
Patrick Hardy France 21 326 0.9× 191 1.2× 153 1.0× 141 1.0× 102 0.7× 47 1.4k
Chadi A. Calarge United States 24 633 1.8× 254 1.6× 151 1.0× 268 1.9× 93 0.7× 72 1.6k
Marc Combrinck United Kingdom 24 482 1.4× 186 1.1× 93 0.6× 525 3.7× 217 1.6× 38 2.1k
Michael J. Esser Canada 27 205 0.6× 148 0.9× 175 1.2× 606 4.2× 85 0.6× 73 2.0k
M. Goudemand France 22 438 1.3× 231 1.4× 203 1.4× 43 0.3× 104 0.8× 80 1.4k
Aroldo Dargél France 16 510 1.5× 101 0.6× 61 0.4× 222 1.6× 148 1.1× 27 1.4k

Countries citing papers authored by I. Schweitzer

Since Specialization
Citations

This map shows the geographic impact of I. Schweitzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Schweitzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Schweitzer more than expected).

Fields of papers citing papers by I. Schweitzer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Schweitzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Schweitzer. The network helps show where I. Schweitzer may publish in the future.

Co-authorship network of co-authors of I. Schweitzer

This figure shows the co-authorship network connecting the top 25 collaborators of I. Schweitzer. A scholar is included among the top collaborators of I. Schweitzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Schweitzer. I. Schweitzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Schweitzer, I., et al.. (2023). Analysis of possible risk predictors in patients with coronavirus disease 2019: a retrospective cohort study. Revista da Associação Médica Brasileira. 69(5). e20220917–e20220917.
3.
Sarris, Jerome, Andrew Scholey, Rebecca King, et al.. (2012). Does a Medicinal Dose of Kava Impair Driving? A Randomized, Placebo-Controlled, Double-Blind Study. Traffic Injury Prevention. 14(1). 13–17. 10 indexed citations
4.
Schweitzer, I., K P Maguire, & Chee H. Ng. (2005). Should bipolar disorder be viewed as manic disorder? Implications for bipolar depression. Bipolar Disorders. 7(5). 418–423. 18 indexed citations
5.
Schweitzer, I., et al.. (2004). Relative efficacy of high dose right unilateral, moderate dose right unilateral and low dose bilateral electroconvulsive therapy. Biological Psychiatry. 55. 2 indexed citations
6.
Schweitzer, I., G. D. Burrows, Virginia Tuckwell, et al.. (2001). Sustained Response to Open-Label Venlafaxine in Drug-Resistant Major Depression. Journal of Clinical Psychopharmacology. 21(2). 185–189. 24 indexed citations
7.
Schweitzer, I.. (2001). Does risperidone have a place in the treatment of nonschizophrenic patients?. International Clinical Psychopharmacology. 16(1). 1–19. 23 indexed citations
8.
Schweitzer, I., Virginia Tuckwell, K P Maguire, & J. W. G. Tiller. (2001). Personality pathology, depression and HPA axis functioning. Human Psychopharmacology Clinical and Experimental. 16(4). 303–308. 15 indexed citations
9.
Parker, Gordon, K. Roy, Philip B. Mitchell, et al.. (2000). Subtyping depression by clinical features:the Australasian database. Acta Psychiatrica Scandinavica. 101(1). 21–28. 20 indexed citations
10.
O’Brien, John T., Patricia Desmond, David Ames, et al.. (1997). Temporal lobe magnetic resonance imaging can differentiate Alzheimer's disease from normal ageing, depression, vascular dementia and other causes of cognitive impairment. Psychological Medicine. 27(6). 1267–1275. 68 indexed citations
11.
O’Brien, John T., David Ames, I. Schweitzer, Maree Mastwyk, & Peter G. Colman. (1996). Enhanced adrenal sensitivity to adrenocorticotrophic hormone (ACTH) is evidence of HPA axis hyperactivity in Alzheimer's disease. Psychological Medicine. 26(1). 7–14. 58 indexed citations
12.
Walker, Rob, et al.. (1996). Renal function after 20 years of lithium therapy. European Neuropsychopharmacology. 6. 9–9. 1 indexed citations
13.
Hopwood, Malcolm, et al.. (1996). Central noradrenergic and serotonergic neurotransmitter function in chronic PTSD. European Neuropsychopharmacology. 6. 81–81. 1 indexed citations
14.
Desmond, Patricia, John T. O’Brien, Brian M. Tress, et al.. (1994). Volumetric and visual assessment of the mesial temporal structures in Alzheimer's disease. Australian and New Zealand Journal of Medicine. 24(5). 547–553. 26 indexed citations
15.
O’Brien, John T., Patricia Desmond, David Ames, et al.. (1994). The differentiation of depression from dementia by temporal lobe magnetic resonance imaging. Psychological Medicine. 24(3). 633–640. 47 indexed citations
16.
Schweitzer, I., et al.. (1992). The provision of public health nursing follow-up services for postnatal clients in Ontario: a cross-sectional survey.. PubMed. 83(3). 200–2. 2 indexed citations
17.
Schweitzer, I., Virginia Tuckwell, K P Maguire, et al.. (1991). Plasma cortisol and 11-deoxycortisol activity in depressed patients and normal volunteers. Psychoneuroendocrinology. 16(5). 375–382. 3 indexed citations
18.
Maguire, K P, Virginia Tuckwell, I. Schweitzer, John Tiller, & Bronwyn Davies. (1990). Dexamethasone kinetics in depressed patients before and after clinical response. Psychoneuroendocrinology. 15(2). 113–123. 16 indexed citations
19.
Tiller, J. W. G., K P Maguire, I. Schweitzer, et al.. (1988). The dexamethasone suppression test: A study in a normal population. Psychoneuroendocrinology. 13(5). 377–384. 19 indexed citations
20.
Maguire, K P, et al.. (1987). The dexamethasone suppression test: Importance of dexamethasone concentrations. Biological Psychiatry. 22(8). 957–967. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chengge Gao Breakdown of academic impact, for papers by Yaffa Vered Breakdown of academic impact, for papers by Lars‐Håkan Thorell Breakdown of academic impact, for papers by Patrick Hardy Breakdown of academic impact, for papers by Chadi A. Calarge Breakdown of academic impact, for papers by Marc Combrinck Breakdown of academic impact, for papers by Michael J. Esser Breakdown of academic impact, for papers by M. Goudemand Breakdown of academic impact, for papers by Aroldo Dargél
Rankless by CCL
2026